Clinical Trial Update: Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the safety, tolerability and effectiveness of Natalizumab in adolescents with active Crohn's disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Natalizumab (natalizumab)

Snippet

Sponsor: Biogen | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED